Skip to main content

Century Therapeutics, Inc.

IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001850119

In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Century Therapeutics, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of IPSC: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders5465+11
Shares21.1M20.9M−205.0K (−1.0%)
Value$208.7M$107.2M−$101.5M (−48.6%)

New holders (17)

Institutions that held Century Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to IPSC in Q4 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC131,158$672.8K0.00%
Jacobs Levy Equity Management, Inc123,996$636.1K0.00%
Renaissance Technologies LLC105,100$539.0K0.00%
Hudson Bay Capital Management LP76,508$392.5K0.00%
Two Sigma Investments, LP35,862$184.0K0.00%
Squarepoint Ops LLC23,866$122.4K0.00%
Jump Financial, LLC16,400$84.1K0.00%
Virtu Financial LLC15,038$77.0K0.01%
Mirae Asset Global Investments Co., Ltd.12,622$64.8K0.00%
Royce & Associates LP11,430$58.6K0.00%
Qube Research & Technologies Ltd10,632$54.5K0.00%
SG Americas Securities, LLC10,368$53.0K0.00%
Allspring Global Investments Holdings, LLC7,992$41.0K0.00%
Cubist Systematic Strategies, LLC7,762$39.8K0.00%
UBS Group AG5,453$28.0K0.00%
Point72 Middle East FZE1,744$8.95K0.00%
Lazard Asset Management LLC727$3.00K0.00%

Sold out (6)

Institutions that held Century Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of IPSC in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Logos Global Management LP460,075$4.55M
Kettle Hill Capital Management, LLC54,100$535.0K
Nisa Investment Advisors, LLC12,000$126.0K
Walleye Trading LLC12,385$122.0K
Wells Fargo & Company57$1.00K
Capital Advisors, Ltd. LLC34$0